Project Grant R21DE034547
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$205K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides $630,506 to The Johns Hopkins University to develop therapeutic cancer vaccines that are effective against diverse variants of human papillomavirus (HPV) 16, which causes over 50% of cervical cancers globally. The primary goal is to employ novel HPV-driven cervicovaginal cancer models to characterize immune evasion mechanisms of different HPV16 E6/E7 variant proteins, evaluate the...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), funds research to define the role of human papillomavirus (HPV) integration structures in driving heterogeneity and treatment outcomes for HPV-positive oropharyngeal squamous cell carcinoma (HPV+ OPSCC). The total award amount is $1,743,816, with a project period from August 1, 2024 to April 30, 2029. The research aims to:...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $249,000 in funding to The Trustees of the University of Pennsylvania to conduct research aimed at understanding how human papillomavirus (HPV) disrupts the DNA damage response in HPV-positive head and neck squamous cell carcinoma (HNSCC). The goal is to identify vulnerabilities that can be targeted with combination...
This federal Project Grant award, totaling $1,641,683.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The award will fund research by The Trustees of the University of Pennsylvania to explore the interactions between human papillomavirus (HPV) oncoprotein E6 levels, mitochondrial function, and therapy resistance in HPV-positive oropharyngeal squamous cell carcinomas. Key objectives...
This $170,208 Project Grant award was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant will fund a 4-year career development plan for Dr. R. Alex Harbison to become an independent physician-scientist focused on using "polyamine blockade therapy" to enhance immune responses against head and neck squamous cell carcinoma. The research aims to define the mechanisms by which...
This $434,170 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports the development and evaluation of a novel engineered bacterial in situ vaccination platform for oral cancer immunotherapy. The key products and services to be delivered under this award include: Development of potent and programmable non-pathogenic E. coli bacteria that can be biomaterial-encapsulated to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,657,748 Project Grant (Grant No. R01DE034300) to Case Western Reserve University (CWRU) to conduct research on "Dual P300 and P53 Reactivation in HPV+ Head and Neck Cancer." This grant, awarded under the NIDCR's Oral Diseases and Disorders Research program (CFDA 93.121), aims to extensively determine the mechanisms of action of p53 and p300 reactivation in response to the lead compound OHM1 in...
This $229,440 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to investigate the mechanistic basis for differential responses to radio-immunotherapy in head and neck squamous cell carcinoma (HNSCC) and pancreatic ductal adenocarcinoma (PDAC). The research aims to elucidate how the tumor microenvironment, particularly the role of regulatory T cells (Tregs), impacts...
This $329,737 Project Grant awarded on September 12, 2023 by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is supporting the development of a rapid, easy-to-use diagnostic platform for the point-of-care detection of high-risk HPV in saliva. The grantee, Innotech Precision Medicine, Inc., is working to create an innovative electrochemical biosensor that combines CRISPR-Cas12 technology with their...
This $118,763 federal Project Grant award was provided by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), to the University of Arizona to support a research project led by Dr. Robert Jackson. The goal of the project is to assess and characterize the transformative versus productive infection cycles of human papillomavirus type 16 (HPV16) in different oral epithelial subtypes, with a focus on determining...